CHARLES WAMBEBE, PhD, FASCHIEF SCIENTIFIC ADVISORProf. Wambebe is the Founder and Chief Scientific Advisor of IBRI.
Prior to this position, he
was a Short Term Professional with the World Health Organization ReGional Office for Africa
, Brazzaville, Congo.
At the WHO
, Prof Wambebe
assisted the Traditional Medicine Program with development of clinical protocols and providing technical guidance to the Member States of the WHO
African region.Prof Wambebe also represented the WHO on the Partnership Board of the European and Developing Countries Clinical Trials Partnership (EDCTP) and served as a member of the EDCTP-WHO Liaison Group.Previously, Prof Wambebe was the pioneer Director General and Chief Executive Officer of NIPRD.
tenure at the institute, eleven herbal medicines were developed from indigenous plants for the treatment of sickle cell anemia, malaria, HIV/AIDS, peptic ulcer, skin fungal infection, oral contraception and cough.These herbal medicines are currently in various indicated stages of clinical trials.Another accomplishment while at the institute includes extensive ethno-botanical surveys and scientific documentation of over 600 hundred medicinal plants indigenous to Nigerian, in the Nigerian Herbal Pharmacopoeia.Prof. Wambebe has received numerous scientific achievement and leadership awards and serves in various capacities as a Fellow of the Third World Academy of Science, WHO Expert Panel on Traditional Medicine, a member of an African Task Force on HIV/AIDS Disease and the Editor-in-Chief of Phytomedicine and Therapeutics Journal among many other roles.He
has published over 100 articles in neuropharmacology, ethnopharmacology and clinical medicine.His
key research findings include the role of endogenous monoamines in sleep mechanisms, etiology of seizures and temperature regulation, involvement of indigenous endogenous family of neuropeptides derived from diazepam binding inhibitor in anxiety disorders.Prof. Wambebe
in 2001 as a major commitment to building African capacity for clinical trials and for traditional medicinal product development. >> Read more ...